Estrogen and Estrogen Receptor Modulators: Potential Therapeutic Strategies for COVID-19 and Breast Cancer

Owing to the ongoing coronavirus disease 2019 (COVID-19) pandemic, we need to pay a particular focus on the impact of coronavirus infection on breast cancer patients. Approximately 70% of breast cancer patients express estrogen receptor (ER), and intervention therapy for ER has been the primary trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Shuying, Yin, Feiying, Nie, Litao, Wang, Yuqin, Qin, Jian, Chen, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985365/
https://www.ncbi.nlm.nih.gov/pubmed/35399920
http://dx.doi.org/10.3389/fendo.2022.829879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985365/
https://www.ncbi.nlm.nih.gov/pubmed/35399920
http://dx.doi.org/10.3389/fendo.2022.829879

Ejemplares similares